Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-47205
Mwinyi, J; Kullak-Ublick, G A (2010). Hereditäre Defekte hepatobiliärer Transportproteine. Der Gastroenterologe, 5(1):39-48.
|Accepted Version (Creative Commons: Attribution 3.0 Unported
Defects in transport proteins that are expressed at the hepatocyte canalicular membrane can cause severe impairment of hepatobiliary transport processes. Progressive familial intrahepatic cholestasis (PFIC) typically manifests in early childhood. Genetic variants in the aminophospholipid transporter FIC1 (ATP8B1 gene) cause PFIC1, characterized by elevated serum bile acids but normal or only mildly elevated gamma-GT levels. Benign recurrent intrahepatic cholestasis type 1 (BRIC1) is also caused by ATP8B1 mutations. Defects in the function of the bile salt efflux pump (BSEP, ABCB11) cause PFIC2 or BRIC2, depending upon the degree of BSEP impairment. A common BSEP variant, the V444A polymorphism, is commonly found in various types of cholestatic liver injury including drug-induced liver injury (DILI). Finally, dysfunction of the multidrug resistance gene product MDR3 (ABCB4) leads to PFIC3, characterized by low biliary phospholipids and high gamma-GT levels in serum due to bile duct injury. All three transporter genes are also associated with intrahepatic cholestasis of pregnancy. Treatment options include UDCA for milder forms, or liver transplantation for severe pediatric cases.
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Clinical Pharmacology and Toxicology|
|DDC:||610 Medicine & health|
|Deposited On:||02 Mar 2011 12:19|
|Last Modified:||23 Nov 2012 18:16|
|Publisher:||Springer Medizin Verlag|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page